Login / Signup
Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients.
Hiroki Hosoi
Shogo Murata
Toshiki Mushino
Shinobu Tamura
Takashi Sonoki
Published in:
Annals of hematology (2021)
Keyphrases
</>
high dose
stem cell transplantation
end stage renal disease
low dose
ejection fraction
chronic kidney disease
newly diagnosed
diffuse large b cell lymphoma
prognostic factors
bone marrow
stem cells
cell therapy
radiation therapy
mesenchymal stem cells
community dwelling